Axiom Investors LLC Cellectis S.A. Transaction History

Axiom Investors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$15.58 - $28.41 $578,173 - $1.05 Million	-37,110 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$25.99 - $30.6 $646,111 - $760,716	-24,860 Reduced 40.12%	37,110 $1.05 Million
Q2 2018 Aug 13, 2018	BUY	$27.78 - $38.53 $1.72 Million - $2.39 Million	61,970 New	61,970 $1.75 Million

11.2M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $85.1M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.